Country: Кипар
Језик: Грчки
Извор: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
ACICLOVIR
DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629
J05AB01
ACICLOVIR
200MG
TABLETS
ACICLOVIR (0059277893) 200MG
ORAL USE
Εθνική Διαδικασία
ACICLOVIR
Νομικό καθεστώς: Με Ιατρική Συνταγή; PACK WITH 30 TABS IN BLISTER(S) (950003601) 30 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή
COMPARATIVE TABLE – ENGLISH PIL VS GREEK PIL PACKAGE LEAFLET: INFORMATION FOR THE USER VIRUCID 200 MG TABLETS VIRUCID 400 MG TABLETS Aciclovir READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It might harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Virucid is and what it is used for 2. What you need to know before you take Virucid 3. How to take Virucid 4. Possible side effects 5. How to store Virucid 6. Contents of the pack and other information 1. WHAT VIRUCID IS AND WHAT IT IS USED FOR Virucid contains a medicine called aciclovir. This belongs to a group of medicines ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ: ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΤΟΝ ΧΡΉΣΤΗ VIRUCID 200 MG ΔΙΣΚΊΑ VIRUCID 400 MG ΔΙΣΚΊΑ Ακυκλοβίρη ΔΙΑΒΆΣΤΕ ΠΡΟΣΕΚΤΙΚΆ ΟΛΌΚΛΗΡΟ ΤΟ ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ ΠΡΟΤΟΎ ΑΡΧΊΣΕΤΕ ΝΑ ΠΑΊΡΝΕΤΕ ΑΥΤΌ ΤΟ ΦΆΡΜΑΚΟ, ΔΙΌΤΙ ΠΕΡΙΛΑΜΒΆΝΕΙ ΣΗΜΑΝΤΙΚΈΣ ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΣΑΣ. Φυλάξτε αυτό το φύλλο οδηγιών χρήσης. Ίσως χρειαστεί να το διαβάσετε ξανά. Εάν έχετε περαιτέρω απορίες, ρωτήστε το γιατρό ή το φαρμακοποιό σας. Η συνταγή για αυτό το φάρμακο χορηγήθηκε αποκλειστικά για σας. Δεν πρέπει να δώσετε το φάρμακο σε άλλους. Μπορεί να τους προκαλέσει βλάβη, ακόμα και όταν τ Прочитајте комплетан документ
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICAL PRODUCT Virucid 200 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 200 mg aciclovir. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablets. Virucid 200 mg tablets are white, concave, round tablets, scored on one side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Virucid Tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes (excluding neonatal HSV and severe HSV infections in immunocompromised children). Virucid Tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immunocompetent patients. Virucid Tablets are indicated for the prophylaxis of herpes simplex infections in immuno-compromised patients. Virucid Tablets are indicated for the treatment of varicella (chickenpox) and herpes zoster (shingles) infections. Route of administration: Oral 4.2 POSOLOGY AND METHOD OF ADMINISTRATION 1 Ensure that patients on high doses of aciclovir are adequately hydrated. Dosage in adults Treatment of herpes simplex infections: 200 mg Virucid should be taken five times daily at approximately four hourly intervals omitting the night time dose. Treatment should continue for 5 days, but in severe initial infections this may have to be extended. In severely immunocompromised patients (e.g. after marrow transplant) or in patients with impaired absorption from the gut the dose can be doubled to 400 mg Virucid or alternatively intravenous dosing could be considered. Dosing should begin as early as possible after the start of an infection; for recurrent episodes this should preferably be during the prodromal period or when lesions first appear. Suppression of herpes simplex infections in immunocompetent patients: 200 mg Virucid should be taken four times daily at approximately six-hourly intervals. Many patients may be conveniently managed on a regimen of 400 mg Прочитајте комплетан документ